Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

1700120318

NPI: 1700120318

Deactivated NPI · This NPI was deactivated on 07/31/2023.
$414K
Total Medicaid Paid
35,632
Total Claims
34,063
Beneficiaries
67
Codes Billed
2018-01
First Month
2021-01
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 12,795 $69K
2019 10,412 $95K
2020 12,009 $249K
2021 416 $918.09

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,492 1,416 $119K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,191 940 $88K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,495 1,418 $23K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,176 930 $20K
87581 1,498 1,422 $20K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 435 435 $17K
87486 1,497 1,421 $13K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 161 159 $11K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,130 2,052 $10K
80074 430 427 $9K
86001 137 132 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,117 1,082 $6K
84443 Thyroid stimulating hormone (TSH) 1,666 1,626 $5K
86003 149 144 $5K
80061 Lipid panel 1,740 1,695 $5K
80053 Comprehensive metabolic panel 1,956 1,903 $5K
86038 440 429 $4K
83036 Hemoglobin; glycosylated (A1C) 1,551 1,508 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 223 221 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 223 221 $3K
82607 1,013 971 $3K
84481 495 486 $3K
83935 411 404 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 167 166 $2K
84439 535 525 $2K
99000 940 916 $2K
82746 680 648 $2K
82728 637 606 $2K
84153 555 545 $2K
86677 431 422 $2K
83540 624 597 $2K
81002 1,259 1,239 $1K
86592 405 400 $1K
86701 157 157 $1K
84550 756 746 $1K
86063 417 408 $1K
84466 297 287 $958.04
82043 531 527 $755.07
85651 457 448 $716.70
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 302 258 $697.20
86430 429 420 $616.24
84480 374 359 $584.47
86140 452 443 $570.10
0100U 14 13 $500.00
84436 349 344 $455.90
83550 188 186 $354.64
36415 Collection of venous blood by venipuncture 1,046 961 $342.53
82670 111 111 $245.85
80164 61 61 $215.71
84479 240 236 $205.14
84144 71 71 $90.60
84402 14 14 $68.04
83001 71 71 $65.00
83002 71 71 $64.88
80076 74 74 $31.66
84146 58 58 $17.11
83735 13 13 $5.42
87507 26 26 $0.00
86704 25 25 $0.00
81226 36 36 $0.00
87340 14 14 $0.00
86706 13 13 $0.00
81015 28 28 $0.00
81225 36 36 $0.00
86803 16 16 $0.00
86708 13 13 $0.00
83970 13 13 $0.00